Skip to main content
TipRanks
Go Ultimate75% OFF

Guardant Health (GH) Stock Statistics & Valuation Metrics

2,306 Followers

Total Valuation

Guardant Health has a market cap or net worth of $19.49B. The enterprise value is $24.64B.

Market Cap
$19.49B
Enterprise Value
$24.64B

Share Statistics

Guardant Health has 135,285,980 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
135,285,980
Owned by Insiders
1.85%
Owned by Institutions
95.48%

Financial Efficiency

Guardant Health’s return on equity (ROE) is 4.19 and return on invested capital (ROIC) is -25.07%.

Return on Equity (ROE)
4.19
Return on Assets (ROA)
-0.21
Return on Invested Capital (ROIC)
-25.07%
Return on Capital Employed (ROCE)
-0.26
Revenue Per Employee
393.12K
Profits Per Employee
-166.64K
Employee Count
2,498
Asset Turnover
0.49
Inventory Turnover
4.06

Valuation Ratios

The current PE Ratio of Guardant Health is -39.40. Guardant Health’s PEG ratio is 2.98.

PE Ratio
-39.40
PS Ratio
15.34
PB Ratio
-70.63
Price to FCF
-84.49
Price to Operating Cash Flow
-112.33
PEG Ratio
2.98

Income Statement

In the last 12 months, Guardant Health had revenue of 982.02M and earned -416.28M in profits. Earnings per share was -3.32.

Revenue
982.02M
Gross Profit
633.01M
Operating Income
-437.25M
Pretax Income
-417.54M
Net Income
-416.28M
EBITDA
-373.91M
Earnings Per Share (EPS)
-3.32

Cash Flow

In the last 12 months, operating cash flow was -173.48M and capital expenditures -58.67M, giving a free cash flow of -232.15M billion.

Operating Cash Flow
-173.48M
Free Cash Flow
-232.15M
Free Cash Flow per Share
-1.73

Dividends & Yields

Guardant Health pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-1.20%
Earnings Yield
-2.52%

Stock Price Statistics

Beta
1.25
52-Week Price Change
52.62%
50-Day Moving Average
168.65
200-Day Moving Average
133.19
Relative Strength Index (RSI)
34.27
Average Volume (3m)
1.97M

Important Dates

Guardant Health upcoming earnings date is Feb 25, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 05, 2026
Next Earnings Date
Feb 25, 2027
Ex-Dividend Date
―

Financial Position

Guardant Health as a current ratio of 4.84, with Debt / Equity ratio of -1722.08%

Current Ratio
4.84
Quick Ratio
4.56
Debt to Market Cap
0.12
Net Debt to EBITDA
-3.56
Interest Coverage Ratio
-112.20

Taxes

In the past 12 months, Guardant Health has paid -1.26M in taxes.

Income Tax
-1.26M
Effective Tax Rate
0.00

Enterprise Valuation

Guardant Health EV to EBITDA ratio is -45.45, with an EV/FCF ratio of -86.42.

EV to Sales
15.69
EV to EBITDA
-45.45
EV to Free Cash Flow
-86.42
EV to Operating Cash Flow
-115.65

Balance Sheet

Guardant Health has $1.03B in cash and marketable securities with $1.69B in debt, giving a net cash position of -$664.59M billion.

Cash & Marketable Securities
$1.03B
Total Debt
$1.69B
Net Cash
-$664.59M
Net Cash Per Share
-$4.91
Tangible Book Value Per Share
-$2.81

Margins

Gross margin is 65.19%, with operating margin of -39.41%, and net profit margin of -37.93%.

Gross Margin
65.19%
Operating Margin
-39.41%
Pretax Margin
-37.99%
Net Profit Margin
-37.93%
EBITDA Margin
-34.52%
EBIT Margin
-37.59%

Analyst Forecast

The average price target for Guardant Health is $204.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
$204.00
Price Target Upside
41.64% Upside
Analyst Consensus
Strong Buy
Analyst Count
19
Revenue Growth Forecast
41.69%
EPS Growth Forecast
-14.59%

Scores

Smart Score
9
AI Score
47